EUVIMEDEUVIMED entdecken
Crossref

The structural basis of IL-36R proinflammatory signaling mediated by IL-36γ and IL-37

Julie Andries iD, Martin Toul iD, Lisse Thierens iD, Brecht Bekaert iD, Jan Felix iD, Danielle M Clancy, Savvas N Savvides iD

Science Immunology · 06.11.2026 · 11 (125)

DOI: 10.1126/sciimmunol.adw5770 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 06.11.2026. Verfasst von Julie Andries und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium. Hauptthemen laut MEDLINE: Interleukin-1, Receptors, Interleukin-1, Receptors, Interleukin. Die Arbeit nennt 77 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek, Vlaams Instituut voor Biotechnologie, European Union’s Horizon Europe Research and Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The interleukin-36 receptor (IL-36R) drives proinflammatory signaling and is therapeutically targeted by spesolimab in acute skin inflammation. Beyond its three canonical agonists (IL-36α, IL-36β, and IL-36γ), IL-36R was recently proposed to be activated by IL-37. Together with antagonism by IL-36R antagonist (IL-36RA) and IL-38, this creates a complex structure-function landscape that remains poorly understood. Here, we report the cryo–electron microscopy (cryo-EM) structure of human IL-36γ bound to IL-36R and the shared co-receptor IL-1R accessory protein (IL-1RAcP). IL-36γ engages IL-36R with low affinity, enabling high-affinity IL-1RAcP recruitment. IL-37 exhibits the opposite binding signature, binding IL-36R with high affinity but IL-1RAcP weakly. Functional comparison of IL-36R engagement by IL-36γ and IL-37 confirmed their common proinflammatory signature, with IL-36γ exhibiting markedly higher potency, consistent with its more stable signaling complex. Structural comparison of cytokine-bound versus antibody-antagonized IL-36R revealed that spesolimab acts as an allosteric antagonist. This study therefore provides a structural and mechanistic blueprint for IL-36R activation by distinct cytokines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-1Receptors, Interleukin-1Receptors, InterleukinHumansSignal TransductionInterleukin-1 Receptor Accessory ProteinCryoelectron MicroscopyInflammationProtein Binding

Substanzen

Interleukin-1Receptors, Interleukin-1interleukin-36 receptor, humanIL36G protein, humanInterleukin-1 Receptor Accessory ProteinIL37 protein, humanReceptors, Interleukin

Autor:innen und Institutionen

  • Department of Biochemistry and Microbiology, Ghent University, Ghent, Belgium.
  • Unit for Structural Biology, VIB Center for Inflammation Research, Ghent, Belgium.
  • VIB Bioimaging Core, VIB Center for Inflammation Research, Ghent, Belgium.

ORCID-Profile: Julie Andries, Martin Toul, Lisse Thierens, Brecht Bekaert, Jan Felix, Savvas N Savvides

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • Vlaams Instituut voor Biotechnologie
  • European Union’s Horizon Europe Research and Innovation Program

Zitieren

APA

Andries, J., Toul, M., Thierens, L., Bekaert, B., Felix, J., Clancy, D. M., & Savvides, S. N. (2026). The structural basis of IL-36R proinflammatory signaling mediated by IL-36γ and IL-37. Science Immunology, 11(125). https://doi.org/10.1126/sciimmunol.adw5770

Vancouver

Andries J, Toul M, Thierens L, Bekaert B, Felix J, Clancy DM, et al. The structural basis of IL-36R proinflammatory signaling mediated by IL-36γ and IL-37. Science Immunology. 2026;11(125). doi:10.1126/sciimmunol.adw5770

BibTeX
@article{Andries2026,
  author = {Andries, Julie and Toul, Martin and Thierens, Lisse and Bekaert, Brecht and Felix, Jan and Clancy, Danielle M and Savvides, Savvas N},
  title = {The structural basis of IL-36R proinflammatory signaling mediated by IL-36γ and IL-37},
  journal = {Science Immunology},
  year = {2026},
  volume = {11},
  number = {125},
  doi = {10.1126/sciimmunol.adw5770}
}
Kostenlos starten →